BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,544 | +57.5% | 2,478 | +56.6% | 0.00% | – |
Q2 2023 | $11,137 | -74.7% | 1,582 | -70.0% | 0.00% | – |
Q1 2023 | $43,960 | -66.9% | 5,271 | -54.4% | 0.00% | – |
Q4 2022 | $132,812 | -10.3% | 11,569 | -2.1% | 0.00% | – |
Q3 2022 | $148,000 | +18.4% | 11,822 | 0.0% | 0.00% | – |
Q2 2022 | $125,000 | -94.1% | 11,822 | -90.9% | 0.00% | -100.0% |
Q1 2022 | $2,118,000 | -0.2% | 130,260 | -15.0% | 0.00% | +50.0% |
Q4 2021 | $2,122,000 | – | 153,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |